These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8616608)
1. Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan. Advokat C; Rhein FQ Brain Res; 1995 Nov; 699(1):157-60. PubMed ID: 8616608 [TBL] [Abstract][Full Text] [Related]
2. Dextromethorphan potentiates morphine antinociception at the spinal level in rats. Chow LH; Huang EY; Ho ST; Lee TY; Tao PL Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615 [TBL] [Abstract][Full Text] [Related]
3. Morphine and dextrorphan lose antinociceptive activity but exhibit an antispastic action in chronic spinal rats. Advokat C; Mosser H; Hutchinson K Physiol Behav; 1997 Oct; 62(4):799-804. PubMed ID: 9284500 [TBL] [Abstract][Full Text] [Related]
4. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice. Fischer BD; Carrigan KA; Dykstra LA J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820 [TBL] [Abstract][Full Text] [Related]
5. Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats. Bespalov A; Kudryashova M; Zvartau E Eur J Pharmacol; 1998 Jun; 351(3):299-305. PubMed ID: 9721021 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Kozela E; Pilc A; Popik P Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203 [TBL] [Abstract][Full Text] [Related]
7. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats. Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634 [TBL] [Abstract][Full Text] [Related]
8. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan. Bulka A; Wiesenfeld-Hallin Z; Xu XJ Brain Res; 2002 Jun; 942(1-2):95-100. PubMed ID: 12031857 [TBL] [Abstract][Full Text] [Related]
9. NMDA antagonist modulation of morphine antinociception in female vs. male rats. Craft RM; Lee DA Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. Chaplan SR; Malmberg AB; Yaksh TL J Pharmacol Exp Ther; 1997 Feb; 280(2):829-38. PubMed ID: 9023297 [TBL] [Abstract][Full Text] [Related]
11. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat. Redwine KE; Trujillo KA Pharmacol Biochem Behav; 2003 Sep; 76(2):361-72. PubMed ID: 14592689 [TBL] [Abstract][Full Text] [Related]
12. Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. Kozela E; Danysz W; Popik P Eur J Pharmacol; 2001 Jun; 423(1):17-26. PubMed ID: 11438302 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists. Trujillo KA; Akil H Brain Res; 1994 Jan; 633(1-2):178-88. PubMed ID: 8137155 [TBL] [Abstract][Full Text] [Related]
14. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys. Allen RM; Dykstra LA J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554 [TBL] [Abstract][Full Text] [Related]
15. Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats. Haghparast A; Gheitasi IP; Lashgari R Eur J Pain; 2007 Nov; 11(8):855-62. PubMed ID: 17291798 [TBL] [Abstract][Full Text] [Related]
17. Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats. Luger TJ; Lorenz IH; Grabner-Weiss C; Hayashi T Br J Pharmacol; 1995 Mar; 114(5):1097-103. PubMed ID: 7780645 [TBL] [Abstract][Full Text] [Related]
18. Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval. Belozertseva IV; Dravolina OA; Neznanova ON; Danysz W; Bespalov AY Eur J Pharmacol; 2000 May; 396(2-3):77-83. PubMed ID: 10822059 [TBL] [Abstract][Full Text] [Related]
19. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine. Lutfy K; Doan P; Weber E Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659 [TBL] [Abstract][Full Text] [Related]
20. Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity. Damaj MI; Flood P; Ho KK; May EL; Martin BR J Pharmacol Exp Ther; 2005 Feb; 312(2):780-5. PubMed ID: 15356218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]